Clinical Trials Directory

Trials / Completed

CompletedNCT04555031

Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Approximately 20 habitual soft contact lens wearing participants will be enrolled in this unilateral, randomized, double-masked (participant and investigator masked) repeated measures insertion study. All participants will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If participants satisfy all eligibility criteria and none of the exclusion criteria, subjects will insert study lenses in random, successive order according to unique randomization schedules that will be provided to each Investigator.

Conditions

Interventions

TypeNameDescription
DEVICEkalifilcon A lensesParticipant will wear the lens for each timepoint of 5, 10 and 15 minutes. A new lens will be inserted for each timepoint.
DEVICEDalies Total 1Participant will wear the lens for each timepoint of 5, 10 and 15 minutes. A new lens will be inserted for each timepoint.
DEVICEPrecision 1Participant will wear the lens for each timepoint of 5, 10 and 15 minutes. A new lens will be inserted for each timepoint.
DEVICEBiotrue ONEdayParticipant will wear the lens for each timepoint of 5, 10 and 15 minutes. A new lens will be inserted for each timepoint.

Timeline

Start date
2020-09-09
Primary completion
2020-09-16
Completion
2020-09-16
First posted
2020-09-18
Last updated
2021-11-08
Results posted
2021-11-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04555031. Inclusion in this directory is not an endorsement.